SURVODUTIDE FOR OBESITY IN CHINESE ADULTS: PHASE 3 RANDOMIZED TRIAL DESIGN AND BASELINE CHARACTERISTICS (SYNCHRONIZE™-CN)

Descargar Publicación
Demystifying the link between ultra-processed food, gut microbiome dysbiosis, and colon cancer: a narrative and bibliometric review Oral nonpeptide GLP-1 receptor agonist VCT220 for obesity treatment: a randomized, double-blind, phase II trial